Lexington Biosciences Holdings Corp
OTC:LXGTF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lexington Biosciences Holdings Corp
OTC:LXGTF
|
CA |
|
Kapuas Prima Coal Tbk PT
IDX:ZINC
|
ID |
Income Statement
Earnings Waterfall
Lexington Biosciences Holdings Corp
Income Statement
Lexington Biosciences Holdings Corp
| Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Selling, General & Administrative |
(1)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Research & Development |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(1)
N/A
|
(1)
+22%
|
(1)
-95%
|
(1)
-12%
|
(1)
+5%
|
(0)
+57%
|
(0)
+12%
|
(0)
+47%
|
(0)
-62%
|
(0)
+10%
|
(0)
-5%
|
(0)
-13%
|
(0)
+38%
|
(0)
+26%
|
(0)
-24%
|
(0)
+13%
|
(0)
-2%
|
(0)
+8%
|
(0)
+4%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Interest Income Expense |
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(1)
N/A
|
(1)
-86%
|
(1)
+9%
|
(1)
-11%
|
(1)
+4%
|
(0)
+61%
|
(0)
+12%
|
(0)
+47%
|
(0)
-62%
|
(0)
+10%
|
(0)
-5%
|
(0)
-13%
|
(0)
+38%
|
(0)
+26%
|
(0)
-24%
|
(0)
+13%
|
(0)
-2%
|
(0)
+8%
|
(0)
+4%
|
|
| Net Income | ||||||||||||||||||||
| Income from Continuing Operations |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Income (Common) |
(1)
N/A
|
(1)
-86%
|
(1)
+9%
|
(1)
-11%
|
(1)
+4%
|
(0)
+61%
|
(0)
+12%
|
(0)
+47%
|
(0)
-62%
|
(0)
+10%
|
(0)
-5%
|
(0)
-13%
|
(0)
+38%
|
(0)
+26%
|
(0)
-24%
|
(0)
+13%
|
(0)
-2%
|
(0)
+8%
|
(0)
+4%
|
|
| EPS (Diluted) |
-0.18
N/A
|
-0.34
-89%
|
-0.31
+9%
|
-0.25
+19%
|
-0.1
+60%
|
-0.04
+60%
|
-0.01
+75%
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
|